GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

84 participants · First posted Oct 25, 2017

Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients

52 participants · First posted Dec 17, 2009

Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

10 participants · First posted Mar 19, 2015

nPT-CLN series (Biotica)

FOV-1201

Tacrolimus(Advagraf, Astagraf, Envarsus, Modigraf, Prograf, Protopic, Tacforius)

C₄₄H₆₉NO₁₂ · Rx

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

LifeMine Therapeutics Initiates First-in-Human Trial of Novel Calcineurin Inhibitor LIFE-001

LifeMine Therapeutics Raises $263M to Advance Novel Calcineurin Inhibitor LIFE-001 for Organ Transplant Rejection

Eledon Pharmaceuticals Completes Enrollment in Phase 2 BESTOW Trial of Tegoprubart for Kidney Transplant Rejection